/Abbott%20Laboratories%20logo-by%20360b%20via%20Shutterstock.jpg)
Illinois-based Abbott Laboratories (ABT) discovers, develops, manufactures, and sells healthcare products. Valued at $190.9 billion by market cap, ABT is a global leader in the large and growing in-vitro diagnostic market, and its products include pharmaceuticals, nutritional, diagnostics, and vascular products.
Shares of this medical device manufacturer have struggled to keep up with the broader market over the past year. ABT stock has gained 4% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 18.2%. In 2024, ABT stock is down marginally, while the SPX is up 11.5% on a YTD basis.